CA
TNDM icon

Continuum Advisory’s Tandem Diabetes Care TNDM Stock Holding History

Continuum Advisory’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.51K Buy
+100
New +$1.75K ﹤0.01% 1790
2025
Q2 		– Sell
-100
Closed -$1.92K – 1461
2025
Q1 		$1.92K Hold
100
– – ﹤0.01% 1359
2024
Q4 		$3.6K Hold
100
– – ﹤0.01% 1221
2024
Q3 		$2.86K Buy
+100
New +$4.24K ﹤0.01% 1313

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Continuum Advisory's TNDM Position: Q2 2026 in Review

Continuum Advisory opened a new position in Tandem Diabetes Care (TNDM) in Q2 2026: 100 shares worth $1.51K. The stake represents ﹤0.01% of the portfolio and ranks #1790 among its holdings. This is a return to the name: Continuum Advisory previously reported a position in TNDM as recently as Q1 2025.

Continuum Advisory first reported a position in TNDM in Q3 2024 and has held it in 4 quarters since. The position peaked at $3.6K in Q4 2024. 273 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Continuum Advisory held 100 shares of Tandem Diabetes Care worth $1.51K as of Q2 2026.
  • Tandem Diabetes Care was a new Continuum Advisory position in Q2 2026.
  • Tandem Diabetes Care made up ﹤0.01% of Continuum Advisory's portfolio in Q2 2026, its #1790 holding.
  • Continuum Advisory first reported a position in Tandem Diabetes Care in Q3 2024 and has held it in 4 quarters since.
  • Continuum Advisory's Tandem Diabetes Care position peaked at $3.6K in Q4 2024.
  • 273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.